Annual EBITDA
$10.77B$82.00M-0.76%
Summary
- Current Value
- As of today, TMO annual EBITDA is $10.77B, down -0.76% on
- Historical Performance
- TMO annual EBITDA is down -16.58% over the past 3 years, and up +64.78% over the past 5 years
- All-Time High Comparison
- TMO annual EBITDA is currently -16.58% below its historical high of $12.91B set on
- 3-Year Low Comparison
- TMO annual EBITDA is at its 3-year low
- Sector Comparison
- TMO annual EBITDA is higher than 98.98% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $10.77B | -0.8% | -16.6% | +64.8% | +465.3% | |
| Quarterly EBITDA | $2.82B | +6.5% | +8.5% | -5.1% | +440.9% | |
| TTM EBITDA | $11.00B | +4.0% | -11.5% | +31.7% | +420.9% | |
| Price | $615.45 | +13.5% | +5.8% | +23.4% | +986.6% | |
| PE Ratio | 35.56 | +8.3% | +7.8% | +13.8% | +58.8% | |
| Annual Revenue | $42.88B | +0.1% | +9.3% | +67.9% | +324.1% | |
| Annual EPS | $16.54 | +7.0% | -15.0% | +80.3% | +722.0% | |
| Annual EBIT | $7.66B | +2.9% | -25.7% | +79.9% | +585.4% | |
| Annual Net Income | $6.34B | +6.4% | -18.0% | +71.5% | +645.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.91B | N/A | -9.5% |
| 5Y | $12.91B | -16.6% | |
| All | $12.91B | -16.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $10.77B | at low | |
| 5Y | $10.22B | N/A | +5.4% |
| All | $7.15M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of TMO?
As of today, TMO annual EBITDA is $10.77B
What is 1-year change in TMO annual EBITDA?
TMO annual EBITDA is down -0.76% year-over-year
What is 3-year change in TMO annual EBITDA?
TMO annual EBITDA is down -16.58% over the past 3 years
How far is TMO annual EBITDA from its all-time high?
TMO annual EBITDA is currently -16.58% below its historical high of $12.91B set on December 31, 2021
How does TMO annual EBITDA rank versus sector peers?
TMO annual EBITDA is higher than 98.98% of companies in Healthcare sector
When is TMO next annual earnings release?
The next annual earnings release for TMO is on
Quarterly EBITDA
$2.82B$182.00M+6.91%
Summary
- Current Value
- As of today, TMO quarterly EBITDA is $2.82B, up +6.91% on
- Historical Performance
- TMO quarterly EBITDA is up +6.47% year-over-year, and up +8.48% over the past 3 years
- All-Time High Comparison
- TMO quarterly EBITDA is currently -24.69% below its historical high of $3.74B set on
- 3-Year Low Comparison
- TMO quarterly EBITDA is +10.61% above its 3-year low of $2.55B reached on
- Sector Comparison
- TMO quarterly EBITDA is higher than 98.37% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.82B | +6.9% | +6.5% | +8.5% | -5.1% | |
| Annual EBITDA | $10.77B | – | -0.8% | -16.6% | +64.8% | |
| TTM EBITDA | $11.00B | +1.6% | +4.0% | -11.5% | +31.7% | |
| Price | $615.45 | +17.3% | +13.5% | +5.8% | +23.4% | |
| PE Ratio | 35.56 | +17.3% | +8.3% | +7.8% | +13.8% | |
| Quarterly Revenue | $11.12B | +2.5% | +4.9% | +4.2% | +30.5% | |
| Quarterly EPS | $4.28 | -0.1% | +0.7% | +12.9% | -11.8% | |
| Quarterly EBIT | $2.08B | +6.6% | +9.0% | +18.2% | -13.2% | |
| Quarterly Net Income | $1.62B | +0.1% | -0.6% | +8.2% | -16.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.01B | N/A | -6.5% |
| 3Y | $3.01B | -6.5% | |
| 5Y | $3.74B | N/A | -24.7% |
| All | $3.74B | -24.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.55B | +10.6% | |
| 3Y | $2.55B | +10.6% | |
| 5Y | $2.55B | +10.6% | |
| All | -$331.10M | +950.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of TMO?
As of today, TMO quarterly EBITDA is $2.82B
What is TMO quarterly EBITDA most recent change?
TMO quarterly EBITDA was up +6.91% on September 27, 2025
What is 1-year change in TMO quarterly EBITDA?
TMO quarterly EBITDA is up +6.47% year-over-year
How far is TMO quarterly EBITDA from its all-time high?
TMO quarterly EBITDA is currently -24.69% below its historical high of $3.74B set on December 31, 2020
How does TMO quarterly EBITDA rank versus sector peers?
TMO quarterly EBITDA is higher than 98.37% of companies in Healthcare sector
When is TMO next earnings release?
The next earnings release for TMO is on
TTM EBITDA
$11.00B$171.00M+1.58%
Summary
- Current Value
- As of today, TMO TTM EBITDA is $11.00B, up +1.58% on
- Historical Performance
- TMO TTM EBITDA is up +4.00% year-over-year, and down -11.52% over the past 3 years
- All-Time High Comparison
- TMO TTM EBITDA is currently -17.40% below its historical high of $13.32B set on
- 3-Year Low Comparison
- TMO TTM EBITDA is +4.00% above its 3-year low of $10.58B reached on
- Sector Comparison
- TMO TTM EBITDA is higher than 98.55% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $11.00B | +1.6% | +4.0% | -11.5% | +31.7% | |
| Annual EBITDA | $10.77B | – | -0.8% | -16.6% | +64.8% | |
| Quarterly EBITDA | $2.82B | +6.9% | +6.5% | +8.5% | -5.1% | |
| Price | $615.45 | +17.3% | +13.5% | +5.8% | +23.4% | |
| PE Ratio | 35.56 | +17.3% | +8.3% | +7.8% | +13.8% | |
| TTM Revenue | $43.74B | +1.2% | +3.2% | -1.0% | +53.5% | |
| TTM EPS | $17.31 | +0.2% | +8.5% | -2.7% | +41.7% | |
| TTM EBIT | $8.13B | +2.2% | +10.3% | -11.8% | +34.3% | |
| TTM Net Income | $6.58B | -0.1% | +7.4% | -6.7% | +34.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.00B | at high | |
| 3Y | $11.91B | N/A | -7.6% |
| 5Y | $13.32B | -17.4% | |
| All | $13.32B | -17.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $10.75B | +2.4% | |
| 3Y | $10.58B | +4.0% | |
| 5Y | $10.25B | N/A | +7.4% |
| All | -$36.90M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of TMO?
As of today, TMO TTM EBITDA is $11.00B
What is TMO TTM EBITDA most recent change?
TMO TTM EBITDA was up +1.58% on September 27, 2025
What is 1-year change in TMO TTM EBITDA?
TMO TTM EBITDA is up +4.00% year-over-year
How far is TMO TTM EBITDA from its all-time high?
TMO TTM EBITDA is currently -17.40% below its historical high of $13.32B set on September 1, 2021
How does TMO TTM EBITDA rank versus sector peers?
TMO TTM EBITDA is higher than 98.55% of companies in Healthcare sector
When is TMO next earnings release?
The next earnings release for TMO is on
EBITDA Formula
Data Sources & References
- TMO Official Website www.thermofisher.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/97745/000009774525000150/0000097745-25-000150-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/97745/000009774525000010/0000097745-25-000010-index.htm
- TMO Profile on Yahoo Finance finance.yahoo.com/quote/TMO
- TMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmo